Puma Liabilities And Stockholders Equity from 2010 to 2024

PBYI Stock  USD 4.01  0.01  0.25%   
Puma Biotechnology's Liabilities And Stockholders Equity is increasing with slightly volatile movements from year to year. Liabilities And Stockholders Equity is predicted to flatten to about 165.1 M. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Puma Biotechnology's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2007-09-30
Previous Quarter
230.5 M
Current Value
214.1 M
Quarterly Volatility
104.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Puma Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Puma main balance sheet or income statement drivers, such as Interest Expense of 14 M, Other Operating Expenses of 174.6 M or Operating Income of 34.9 M, as well as many exotic indicators such as Price To Sales Ratio of 0.91, Dividend Yield of 0.0 or PTB Ratio of 3.63. Puma financial statements analysis is a perfect complement when working with Puma Biotechnology Valuation or Volatility modules.
  
This module can also supplement Puma Biotechnology's financial leverage analysis and stock options assessment as well as various Puma Biotechnology Technical models . Check out the analysis of Puma Biotechnology Correlation against competitors.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.

Latest Puma Biotechnology's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Puma Biotechnology over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Puma Biotechnology's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Puma Biotechnology's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Puma Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean181,081,510
Geometric Mean130,990,104
Coefficient Of Variation42.63
Mean Deviation61,519,189
Median222,051,000
Standard Deviation77,193,330
Sample Variance5958.8T
Range257.7M
R-Value0.68
Mean Square Error3464.8T
R-Squared0.46
Significance0.01
Slope11,707,991
Total Sum of Squares83423.3T

Puma Liabilities And Stockholders Equity History

2024165.1 M
2023230.5 M
2022222.1 M
2021226.6 M
2020244.2 M
2019234.9 M
2018259.1 M

About Puma Biotechnology Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Puma Biotechnology income statement, its balance sheet, and the statement of cash flows. Puma Biotechnology investors use historical funamental indicators, such as Puma Biotechnology's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Puma Biotechnology investors may use each financial statement separately, they are all related. The changes in Puma Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Puma Biotechnology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Puma Biotechnology Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Puma Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity230.5 M165.1 M

Currently Active Assets on Macroaxis

When determining whether Puma Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Puma Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puma Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puma Biotechnology Stock:
Check out the analysis of Puma Biotechnology Correlation against competitors.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Puma Stock analysis

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.78)
Earnings Share
0.32
Revenue Per Share
4.769
Quarterly Revenue Growth
(0.17)
Return On Assets
0.081
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.